VANCOUVER, British Columbia--(BUSINESS WIRE)--Sept. 8, 2006--ProtoKinetix, Inc. (OTCBB:PKTX) is pleased to report on the outstanding reception AAGP(TM) received from the scientific and pharmaceutical establishments attending the prestigious GECO(47) symposium. PKTX has been requested by several pharmaceutical companies to collaborate with them on a variety of exciting new applications for the family of AAGP(TM) molecules.
